{"pmid":32433291,"title":"Tracheobronchial Slough, a Potential Pathology in Endotracheal Tube Obstruction in Patients With Coronavirus Disease 2019 (COVID-19) in the Intensive Care Setting.","text":["Tracheobronchial Slough, a Potential Pathology in Endotracheal Tube Obstruction in Patients With Coronavirus Disease 2019 (COVID-19) in the Intensive Care Setting.",": Treatment of the COVID-19 critically ill patient requires oxygenation and ventilation support for prolonged periods which seem unique for viral pneumonia. The pathophysiology of COVID-19 critical illness is being revealed on a day to day basis at the frontlines of care in the intensive care unit with this new disease. High density consolidations in the bronchial tree and in the pulmonary parenchyma have been described in the advanced phase of the disease. Our team has observed impeded ventilation in intubated patients who are several days into the critical course due to what seems to be tissue sloughing with resultant endotracheal tube obstruction and the consequences thereof. Caregivers need to be aware of this pathological finding, recognize, and to treat this aspect of the COVID-19 critical illness course, which is becoming more prevalent.","Ann Surg","Rubano, Jerry A","Jasinski, Patrick T","Rutigliano, Daniel N","Tassiopoulos, Apostolos K","Davis, James E","Beg, Tazeen","Poovathoor, Shaji","Bergese, Sergio D","Ahmad, Sahar","Jawa, Randeep S","Vosswinkel, James A","Talamini, Mark A","32433291"],"abstract":[": Treatment of the COVID-19 critically ill patient requires oxygenation and ventilation support for prolonged periods which seem unique for viral pneumonia. The pathophysiology of COVID-19 critical illness is being revealed on a day to day basis at the frontlines of care in the intensive care unit with this new disease. High density consolidations in the bronchial tree and in the pulmonary parenchyma have been described in the advanced phase of the disease. Our team has observed impeded ventilation in intubated patients who are several days into the critical course due to what seems to be tissue sloughing with resultant endotracheal tube obstruction and the consequences thereof. Caregivers need to be aware of this pathological finding, recognize, and to treat this aspect of the COVID-19 critical illness course, which is becoming more prevalent."],"journal":"Ann Surg","authors":["Rubano, Jerry A","Jasinski, Patrick T","Rutigliano, Daniel N","Tassiopoulos, Apostolos K","Davis, James E","Beg, Tazeen","Poovathoor, Shaji","Bergese, Sergio D","Ahmad, Sahar","Jawa, Randeep S","Vosswinkel, James A","Talamini, Mark A"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32433291","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1097/SLA.0000000000004031","topics":["Mechanism","Treatment"],"weight":1,"_version_":1667342288241557504,"score":9.490897,"similar":[{"pmid":32503800,"title":"Prone positioning in conscious patients on medical wards: A review of the evidence and its relevance to patients with COVID-19 infection.","text":["Prone positioning in conscious patients on medical wards: A review of the evidence and its relevance to patients with COVID-19 infection.","Medical teams continue to treat many patients with COVID-19 infection. This disease can result in profound hypoxaemia that may necessitate intubation and invasive mechanical ventilation in those who are critically ill. This intervention carries risk to both patients and healthcare workers and utilises significant hospital resource for prolonged periods. Simple, safe interventions that can be used before critical deterioration are highly desirable. The prone position in conscious non-ventilated patients with COVID-19 infection may improve oxygenation in the short term and defer or prevent the need for intubation in some. However, clinicians must be aware that there is a small evidence base for this intervention currently. This review sets out evidence regarding the use of this technique to aid the decision making of frontline staff.","Clin Med (Lond)","Chad, Thomas","Sampson, Caroline","32503800"],"abstract":["Medical teams continue to treat many patients with COVID-19 infection. This disease can result in profound hypoxaemia that may necessitate intubation and invasive mechanical ventilation in those who are critically ill. This intervention carries risk to both patients and healthcare workers and utilises significant hospital resource for prolonged periods. Simple, safe interventions that can be used before critical deterioration are highly desirable. The prone position in conscious non-ventilated patients with COVID-19 infection may improve oxygenation in the short term and defer or prevent the need for intubation in some. However, clinicians must be aware that there is a small evidence base for this intervention currently. This review sets out evidence regarding the use of this technique to aid the decision making of frontline staff."],"journal":"Clin Med (Lond)","authors":["Chad, Thomas","Sampson, Caroline"],"date":"2020-06-07T11:00:00Z","year":2020,"_id":"32503800","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.7861/clinmed.2020-0179","keywords":["covid-19","acute respiratory failure","hypoxaemia","oxygenation","prone"],"topics":["Treatment","Prevention"],"weight":1,"_version_":1668892488299970560,"score":137.87384},{"pmid":32248675,"title":"Critically ill patients with COVID-19 in Hong Kong: a multicentre retrospective observational cohort study","text":["Critically ill patients with COVID-19 in Hong Kong: a multicentre retrospective observational cohort study","Objective: To report the first eight cases of critically ill patients with coronavirus disease 2019 (COVID-19) in Hong Kong, describing the treatments and supportive care they received and their 28-day outcomes. Design: Multicentre retrospective observational cohort study. Setting: Three multidisciplinary intensive care units (ICUs) in Hong Kong. Participants: All adult critically ill patients with confirmed COVID-19 admitted to ICUs in Hong Kong between 22 January and 11 February 2020. Main outcome measure: 28-day mortality. Results: Eight out of 49 patients with COVID-19 (16%) were admitted to Hong Kong ICUs during the study period. The median age was 64.5 years (range, 42-70) with a median admission Sequential Organ Failure Assessment (SOFA) score of 6 (IQR, 4-7). Six patients (75%) required mechanical ventilation, six patients (75%) required vasopressors and two (25%) required renal replacement therapy. None of the patients required prone ventilation, nitric oxide or extracorporeal membrane oxygenation. The median times to shock reversal and extubation were 9 and 11 days respectively. At 28 days, one patient (12%) had died and the remaining seven (88%) all survived to ICU discharge. Only one of the survivors (14%) still required oxygen at 28 days. Conclusion: Critically ill patients with COVID-19 often require a moderate duration of mechanical ventilation and vasopressor support. Most of these patients recover and survive to ICU discharge with supportive care using lung protective ventilation strategies, avoiding excess fluids, screening and treating bacterial co-infection, and timely intubation. Lower rather than upper respiratory tract viral burden correlates with clinical severity of illness.","Crit Care Resusc","Ling, Lowell","So, Christina","Shum, Hoi Ping","Chan, Paul K S","Lai, Christopher K C","Kandamby, Darshana H","Ho, Eunise","So, Dominic","Yan, Wing Wa","Lui, Grace","Leung, Wai Shing","Chan, Man Chun","Gomersall, Charles D","32248675"],"abstract":["Objective: To report the first eight cases of critically ill patients with coronavirus disease 2019 (COVID-19) in Hong Kong, describing the treatments and supportive care they received and their 28-day outcomes. Design: Multicentre retrospective observational cohort study. Setting: Three multidisciplinary intensive care units (ICUs) in Hong Kong. Participants: All adult critically ill patients with confirmed COVID-19 admitted to ICUs in Hong Kong between 22 January and 11 February 2020. Main outcome measure: 28-day mortality. Results: Eight out of 49 patients with COVID-19 (16%) were admitted to Hong Kong ICUs during the study period. The median age was 64.5 years (range, 42-70) with a median admission Sequential Organ Failure Assessment (SOFA) score of 6 (IQR, 4-7). Six patients (75%) required mechanical ventilation, six patients (75%) required vasopressors and two (25%) required renal replacement therapy. None of the patients required prone ventilation, nitric oxide or extracorporeal membrane oxygenation. The median times to shock reversal and extubation were 9 and 11 days respectively. At 28 days, one patient (12%) had died and the remaining seven (88%) all survived to ICU discharge. Only one of the survivors (14%) still required oxygen at 28 days. Conclusion: Critically ill patients with COVID-19 often require a moderate duration of mechanical ventilation and vasopressor support. Most of these patients recover and survive to ICU discharge with supportive care using lung protective ventilation strategies, avoiding excess fluids, screening and treating bacterial co-infection, and timely intubation. Lower rather than upper respiratory tract viral burden correlates with clinical severity of illness."],"journal":"Crit Care Resusc","authors":["Ling, Lowell","So, Christina","Shum, Hoi Ping","Chan, Paul K S","Lai, Christopher K C","Kandamby, Darshana H","Ho, Eunise","So, Dominic","Yan, Wing Wa","Lui, Grace","Leung, Wai Shing","Chan, Man Chun","Gomersall, Charles D"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32248675","source":"PubMed","week":"202015|Apr 06 - Apr 12","locations":["China","China","China","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Nitric Oxide"],"topics":["Case Report"],"weight":1,"_version_":1666138491006746624,"score":126.946625},{"pmid":32323287,"title":"[Position Paper for the State of the Art Application of Respiratory Support in Patients with COVID-19 - German Respiratory Society].","text":["[Position Paper for the State of the Art Application of Respiratory Support in Patients with COVID-19 - German Respiratory Society].","Against the background of the pandemic caused by infection with the SARS-CoV-2, the German Society for Pneumology and Respiratory Medicine (DGP e.V.), in cooperation with other associations, has designated a team of experts in order to answer the currently pressing questions about therapy strategies in dealing with COVID-19 patients suffering from acute respiratory insufficiency (ARI).The position paper is based on the current knowledge that is evolving daily. Many of the published and cited studies require further review, also because many of them did not undergo standard review processes.Therefore, this position paper is also subject to a continuous review process and will be further developed in cooperation with the other professional societies.This position paper is structured into the following five topics:1. Pathophysiology of acute respiratory insufficiency in patients without immunity infected with SARS-CoV-22. Temporal course and prognosis of acute respiratory insufficiency during the course of the disease3. Oxygen insufflation, high-flow oxygen, non-invasive ventilation and invasive ventilation with special consideration of infectious aerosol formation4. Non-invasive ventilation in ARI5. Supply continuum for the treatment of ARIKey points have been highlighted as core statements and significant observations. Regarding the pathophysiological aspects of acute respiratory insufficiency (ARI), the pulmonary infection with SARS-CoV-2 COVID-19 runs through three phases: early infection, pulmonary manifestation and severe hyperinflammatory phase.There are differences between advanced COVID-19-induced lung damage and those changes seen in Acute Respiratory Distress Syndromes (ARDS) as defined by the Berlin criteria. In a pathophysiologically plausible - but currently not yet histopathologically substantiated - model, two types (L-type and H-type) are distinguished, which correspond to an early and late phase. This distinction can be taken into consideration in the differential instrumentation in the therapy of ARI.The assessment of the extent of ARI should be carried out by an arterial or capillary blood gas analysis under room air conditions and must include the calculation of the oxygen supply (measured from the variables of oxygen saturation, the Hb value, the corrected values of the Hufner number and the cardiac output). In principle, aerosols can cause transmission of infectious viral particles. Open systems or leakage systems (so-called vented masks) can prevent the release of respirable particles. Procedures in which the invasive ventilation system must be opened, and endotracheal intubation must be carried out are associated with an increased risk of infection.The protection of personnel with personal protective equipment should have very high priority because fear of contagion must not be a primary reason for intubation. If the specifications for protective equipment (eye protection, FFP2 or FFP-3 mask, gown) are adhered to, inhalation therapy, nasal high-flow (NHF) therapy, CPAP therapy or NIV can be carried out according to the current state of knowledge without increased risk of infection to the staff. A significant proportion of patients with respiratory failure presents with relevant hypoxemia, often also caused by a high inspiratory oxygen fraction (FiO2) including NHF, and this hypoxemia cannot be not completely corrected. In this situation, CPAP/NIV therapy can be administered under use of a mouth and nose mask or a respiratory helmet as therapy escalation, as long as the criteria for endotracheal intubation are not fulfilled.In acute hypoxemic respiratory insufficiency, NIV should be performed in an intensive care unit or in a comparable unit by personnel with appropriate expertise. Under CPAP/NIV, a patient can deteriorate rapidly. For this reason, continuous monitoring with readiness to carry out intubation must be ensured at all times. If CPAP/NIV leads to further progression of ARI, intubation and subsequent invasive ventilation should be carried out without delay if no DNI order is in place.In the case of patients in whom invasive ventilation, after exhausting all guideline-based measures, is not sufficient, extracorporeal membrane oxygenation procedure (ECMO) should be considered to ensure sufficient oxygen supply and to remove CO2.","Pneumologie","Pfeifer, M","Ewig, S","Voshaar, T","Randerath, W","Bauer, T","Geiseler, J","Dellweg, D","Westhoff, M","Windisch, W","Schonhofer, B","Kluge, S","Lepper, P M","32323287"],"journal":"Pneumologie","authors":["Pfeifer, M","Ewig, S","Voshaar, T","Randerath, W","Bauer, T","Geiseler, J","Dellweg, D","Westhoff, M","Windisch, W","Schonhofer, B","Kluge, S","Lepper, P M"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32323287","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1055/a-1157-9976","locations":["Berlin"],"countries":["Germany"],"countries_codes":["DEU|Germany"],"topics":["Treatment","Prevention"],"weight":1,"abstract":["Against the background of the pandemic caused by infection with the SARS-CoV-2, the German Society for Pneumology and Respiratory Medicine (DGP e.V.), in cooperation with other associations, has designated a team of experts in order to answer the currently pressing questions about therapy strategies in dealing with COVID-19 patients suffering from acute respiratory insufficiency (ARI).The position paper is based on the current knowledge that is evolving daily. Many of the published and cited studies require further review, also because many of them did not undergo standard review processes.Therefore, this position paper is also subject to a continuous review process and will be further developed in cooperation with the other professional societies.This position paper is structured into the following five topics:1. Pathophysiology of acute respiratory insufficiency in patients without immunity infected with SARS-CoV-22. Temporal course and prognosis of acute respiratory insufficiency during the course of the disease3. Oxygen insufflation, high-flow oxygen, non-invasive ventilation and invasive ventilation with special consideration of infectious aerosol formation4. Non-invasive ventilation in ARI5. Supply continuum for the treatment of ARIKey points have been highlighted as core statements and significant observations. Regarding the pathophysiological aspects of acute respiratory insufficiency (ARI), the pulmonary infection with SARS-CoV-2 COVID-19 runs through three phases: early infection, pulmonary manifestation and severe hyperinflammatory phase.There are differences between advanced COVID-19-induced lung damage and those changes seen in Acute Respiratory Distress Syndromes (ARDS) as defined by the Berlin criteria. In a pathophysiologically plausible - but currently not yet histopathologically substantiated - model, two types (L-type and H-type) are distinguished, which correspond to an early and late phase. This distinction can be taken into consideration in the differential instrumentation in the therapy of ARI.The assessment of the extent of ARI should be carried out by an arterial or capillary blood gas analysis under room air conditions and must include the calculation of the oxygen supply (measured from the variables of oxygen saturation, the Hb value, the corrected values of the Hufner number and the cardiac output). In principle, aerosols can cause transmission of infectious viral particles. Open systems or leakage systems (so-called vented masks) can prevent the release of respirable particles. Procedures in which the invasive ventilation system must be opened, and endotracheal intubation must be carried out are associated with an increased risk of infection.The protection of personnel with personal protective equipment should have very high priority because fear of contagion must not be a primary reason for intubation. If the specifications for protective equipment (eye protection, FFP2 or FFP-3 mask, gown) are adhered to, inhalation therapy, nasal high-flow (NHF) therapy, CPAP therapy or NIV can be carried out according to the current state of knowledge without increased risk of infection to the staff. A significant proportion of patients with respiratory failure presents with relevant hypoxemia, often also caused by a high inspiratory oxygen fraction (FiO2) including NHF, and this hypoxemia cannot be not completely corrected. In this situation, CPAP/NIV therapy can be administered under use of a mouth and nose mask or a respiratory helmet as therapy escalation, as long as the criteria for endotracheal intubation are not fulfilled.In acute hypoxemic respiratory insufficiency, NIV should be performed in an intensive care unit or in a comparable unit by personnel with appropriate expertise. Under CPAP/NIV, a patient can deteriorate rapidly. For this reason, continuous monitoring with readiness to carry out intubation must be ensured at all times. If CPAP/NIV leads to further progression of ARI, intubation and subsequent invasive ventilation should be carried out without delay if no DNI order is in place.In the case of patients in whom invasive ventilation, after exhausting all guideline-based measures, is not sufficient, extracorporeal membrane oxygenation procedure (ECMO) should be considered to ensure sufficient oxygen supply and to remove CO2."],"_version_":1666138493893476353,"score":122.41821},{"pmid":32455515,"title":"[Clinical feature changes of a COVID-19 patient from mild to critical condition and cardiopulmonary pathological results].","text":["[Clinical feature changes of a COVID-19 patient from mild to critical condition and cardiopulmonary pathological results].","Objective: To analyse the clinical history, laboratory tests and pathological data of a patient who suffered from novel coronavirus pneumonia(COVID-19) and provide reference for the clinical treatment of similar cases. Methods: Data of clinical manifestation, laboratory examination, bronchoscopy, echocardiography and cardiopulmonary pathological results were retrospectively reviewed in a case of COVID-19 with rapid exacerbation from mild to critical condition. Results: This patient hospitalized at day 9 post 2019 novel coronavirus(2019-nCoV) infection, experienced progressive deterioration from mild to severe at day 11, severe to critical at day 18 and underwent extracorporeal membrane oxygenation(ECMO) and continuous renal replacement therapy(CRRT) as well as heart lung transplantation during day 28-45 day post infection, and died on the second day post heart and lung transplantation. The patient had suffered from hypertension for 8 years. At the early stage of the disease, his symptoms were mild and the inflammatory indices increased and the lymphocyte count decreased continuously. The patient's condition exacerbated rapidly with multi-organ infections, and eventually developed pulmonary hemorrhage and consolidation, pulmonary hypertension, right heart failure, malignant ventricular arrhythmias, liver dysfunction, etc. His clinical manifestations could not be improved despite viral RNAs test results became negative. The patient underwent lung and heart transplantation and finally died of multi organ failure at the second day post lung and heart transplantation. Pathological examination indicated massive mucus, dark red secretions and blood clots in bronchus. The pathological changes were mainly diffused pulmonary hemorrhagic injuries and necrosis, fibrosis, small vessel disease with cardiac edema and lymphocyte infiltration. Conclusions: The clinical course of COVID-19 can exacerbate rapidly from mild to critical with lung, liver and heart injuries. Steadily increased inflammation indices are suggestive of irreversible disease progression and worse outcome. In the early stages of the disease, the progress of the disease should be closely observed and evaluated, and the factors related to the progress of the disease should be identified and managed.","Zhonghua Xin Xue Guan Bing Za Zhi","Jiang, S W","Gao, H","Wu, L","Wang, G W","Cen, F L","Li, J X","Feng, C","Wen, J M","Chen, Y","He, R L","Qiao, K","Wang, Y","Liu, Y X","Wang, Z Q","32455515"],"abstract":["Objective: To analyse the clinical history, laboratory tests and pathological data of a patient who suffered from novel coronavirus pneumonia(COVID-19) and provide reference for the clinical treatment of similar cases. Methods: Data of clinical manifestation, laboratory examination, bronchoscopy, echocardiography and cardiopulmonary pathological results were retrospectively reviewed in a case of COVID-19 with rapid exacerbation from mild to critical condition. Results: This patient hospitalized at day 9 post 2019 novel coronavirus(2019-nCoV) infection, experienced progressive deterioration from mild to severe at day 11, severe to critical at day 18 and underwent extracorporeal membrane oxygenation(ECMO) and continuous renal replacement therapy(CRRT) as well as heart lung transplantation during day 28-45 day post infection, and died on the second day post heart and lung transplantation. The patient had suffered from hypertension for 8 years. At the early stage of the disease, his symptoms were mild and the inflammatory indices increased and the lymphocyte count decreased continuously. The patient's condition exacerbated rapidly with multi-organ infections, and eventually developed pulmonary hemorrhage and consolidation, pulmonary hypertension, right heart failure, malignant ventricular arrhythmias, liver dysfunction, etc. His clinical manifestations could not be improved despite viral RNAs test results became negative. The patient underwent lung and heart transplantation and finally died of multi organ failure at the second day post lung and heart transplantation. Pathological examination indicated massive mucus, dark red secretions and blood clots in bronchus. The pathological changes were mainly diffused pulmonary hemorrhagic injuries and necrosis, fibrosis, small vessel disease with cardiac edema and lymphocyte infiltration. Conclusions: The clinical course of COVID-19 can exacerbate rapidly from mild to critical with lung, liver and heart injuries. Steadily increased inflammation indices are suggestive of irreversible disease progression and worse outcome. In the early stages of the disease, the progress of the disease should be closely observed and evaluated, and the factors related to the progress of the disease should be identified and managed."],"journal":"Zhonghua Xin Xue Guan Bing Za Zhi","authors":["Jiang, S W","Gao, H","Wu, L","Wang, G W","Cen, F L","Li, J X","Feng, C","Wen, J M","Chen, Y","He, R L","Qiao, K","Wang, Y","Liu, Y X","Wang, Z Q"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32455515","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.3760/cma.j.cn112148-20200304-00155","keywords":["covid-19","clinical feature","extracorporeal membrane oxygenation","heart-lung transplantation","myocardial injury"],"topics":["Treatment","Mechanism","Diagnosis"],"weight":1,"_version_":1667983494552223744,"score":117.7923},{"pmid":32412511,"title":"High-flow cannulas will be required with current COVID-19 crisis, not only mechanical ventilators.","text":["High-flow cannulas will be required with current COVID-19 crisis, not only mechanical ventilators.","COVID-19 is characterized by acute respiratory distress syndrome progression, which ranges from mild to severe. A percentage of critically ill patients will require endotracheal intubation and mechanical ventilation; therefore, Mexican engineers from different places have had the initiative of creating mechanical ventilators. Although artificial ventilator is one of the last resources for the most severely ill patients, there are patients who are on the verge of not meeting the criteria for intubation; if they are directly intubated, the opportunity for them to overcome the severe phase with high concentration supplemental oxygen would be be missed. Intubation per se induces lung damage, increases the risk of superinfection, and the number of days of ICU stay. Furthermore, non-selective use of artificial ventilators decreases the opportunity for patients who require a ventilator to survive and increases institutional care costs of both human and material resources.","Gac Med Mex","Santos, Edgar","Ramirez-Cuapio, Francisco L","Remes-Diaz, Lorena T","Sanchez-Porras, Renan","32412511"],"abstract":["COVID-19 is characterized by acute respiratory distress syndrome progression, which ranges from mild to severe. A percentage of critically ill patients will require endotracheal intubation and mechanical ventilation; therefore, Mexican engineers from different places have had the initiative of creating mechanical ventilators. Although artificial ventilator is one of the last resources for the most severely ill patients, there are patients who are on the verge of not meeting the criteria for intubation; if they are directly intubated, the opportunity for them to overcome the severe phase with high concentration supplemental oxygen would be be missed. Intubation per se induces lung damage, increases the risk of superinfection, and the number of days of ICU stay. Furthermore, non-selective use of artificial ventilators decreases the opportunity for patients who require a ventilator to survive and increases institutional care costs of both human and material resources."],"journal":"Gac Med Mex","authors":["Santos, Edgar","Ramirez-Cuapio, Francisco L","Remes-Diaz, Lorena T","Sanchez-Porras, Renan"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32412511","source":"PubMed","week":"202020|May 11 - May 17","locations":["Mexican"],"countries":["Mexico"],"countries_codes":["MEX|Mexico"],"weight":0,"_version_":1666897319209992193,"score":117.45151}]}